FDA Approves Dupilumab for Chronic Spontaneous Urticaria
Key Points: 1. FDA approves Dupixent as the first new CSU treatment in over a decade. 2. Phase 3 trial ...
Key Points: 1. FDA approves Dupixent as the first new CSU treatment in over a decade. 2. Phase 3 trial ...
Drugmakers Increase Prices on Over 250 Medications Pharmaceutical companies have raised prices on over 250 branded medications in the U.S., ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.